Loading…
Shear-mediated ALK5 expression regulates endothelial activation
Pang, Kuin Tian, Ghim, Mean, Sarathchandra, Padmini, Warboys, Christina M., Yacoub, Magdi H., Chester, Adrian H., Weinberg, Peter D.
Published in Biochemical and biophysical research communications (29.01.2023)
Published in Biochemical and biophysical research communications (29.01.2023)
Get full text
Journal Article
Loading…
P0334 AGMB-129, an investigational ALK5 inhibitor for the treatment of Fibrostenosing Crohn’s Disease (FSCD), shows gastrointestinal (GI) restricted pharmacokinetics (PK) and a favorable safety profile in healthy subjects
Sáez-Borderías, A, Van Kaem, T, Alberti, J, Stiers, P J, Sabadie, C, Van Heeswijk, R, Senso, T, Pampín, B, Bosser, R, Wiesel, P
Published in Journal of Crohn's and colitis (22.01.2025)
Published in Journal of Crohn's and colitis (22.01.2025)
Get full text
Journal Article
Loading…
Disposition and metabolism of [14C]-galunisertib, a TGF-βRI kinase/ALK5 inhibitor, following oral administration in healthy subjects and mechanistic prediction of the effect of itraconazole on galunisertib pharmacokinetics
Cassidy, Kenneth C., Gueorguieva, Ivelina, Miles, Colin, Rehmel, Jessica, Yi, Ping, Ehlhardt, William J.
Published in Xenobiotica (03.04.2018)
Published in Xenobiotica (03.04.2018)
Get full text
Journal Article
Loading…
Alk5/Runx1 signaling mediated by extracellular vesicles promotes vascular repair in acute respiratory distress syndrome
Shah, Trushil, Qin, Shanshan, Vashi, Mona, Predescu, Dan N., Jeganathan, Niranjan, Bardita, Cristina, Ganesh, Balaji, diBartolo, Salvatore, Fogg, Louis F., Balk, Robert A., Predescu, Sanda A.
Published in Clinical and translational medicine (22.06.2018)
Published in Clinical and translational medicine (22.06.2018)
Get full text
Journal Article
Loading…
Correction to: Cassidy et al., Disposition and metabolism of [14C]-galunisertib, a TGF-bRI kinase/ALK5 inhibitor, following oral administration in healthy subjects and mechanistic prediction of the effect of itraconazole on galunisertib pharmacokinetics
Published in Xenobiotica
(03.04.2018)
Get full text
Journal Article
Loading…
Disposition and metabolism of 14C-galunisertib, a TGF-βRI kinase/ALK5 inhibitor, following oral administration in healthy subjects and mechanistic prediction of the effect of itraconazole on galunisertib pharmacokinetics
Cassidy, Kenneth C, Gueorguieva, Ivelina, Miles, Colin, Rehmel, Jessica, Yi, Ping, Ehlhardt, William J
Published in Xenobiotica (01.04.2018)
Published in Xenobiotica (01.04.2018)
Get full text
Journal Article
Loading…
Correction to: Cassidy et al., Disposition and metabolism of 14C-galunisertib, a TGF-bRI kinase/ALK5 inhibitor, following oral administration in healthy subjects and mechanistic prediction of the effect of itraconazole on galunisertib pharmacokinetics
Published in Xenobiotica
(01.04.2018)
Get full text
Journal Article
Loading…
ALK5 INHIBITORS AS SKELETAL MUSCLE HYPERTROPHY INDUCERS
FLAENDER, MÉLANIE, POYDENOT, PAULINE, MICHAUD, JORIS, DUIN-PELLETIER, EVE, SELIG, LUC
Year of Publication 03.07.2025
Get full text
Year of Publication 03.07.2025
Patent
Loading…
ALK5 inhibitors as skeletal muscle hypertrophy inducers
Duchemin-Pelletier, Eve, Flaender, Mélanie, Selig, Luc, Poydenot, Pauline, Michaud, Joris
Year of Publication 20.05.2025
Get full text
Year of Publication 20.05.2025
Patent
Loading…
Loading…
ALK5 INHIBITORS AS SKELETAL MUSCLE HYPERTROPHY INDUCERS
POYDENOT, Pauline, MICHAUD, Joris, DUIN-PELLETIER, Eve, FLAENDER, Mélanie, SELIG, Luc
Year of Publication 27.01.2021
Get full text
Year of Publication 27.01.2021
Patent
Loading…
ALK5 INHIBITORS AS SKELETAL MUSCLE HYPERTROPHY INDUCERS
FLAENDER, MÉLANIE, POYDENOT, PAULINE, MICHAUD, JORIS, DUIN-PELLETIER, EVE, SELIG, LUC
Year of Publication 21.01.2021
Get full text
Year of Publication 21.01.2021
Patent
Loading…
ALK5 INHIBITORS AS SKELETAL MUSCLE HYPERTROPHY INDUCERS
POYDENOT, Pauline, MICHAUD, Joris, DUIN-PELLETIER, Eve, FLAENDER, Mélanie, SELIG, Luc
Year of Publication 26.09.2019
Get full text
Year of Publication 26.09.2019
Patent
Loading…
Loading…
ALK5 INHIBITORS AS SKELETAL MUSCLE HYPERTROPHY INDUCERS
Year of Publication 25.03.2019
Get full text
Patent
Loading…
ALK5 INHIBITORS AS SKELETAL MUSCLE HYPERTROPHY INDUCERS
POYDENOT PAULINE, MICHAUD JORIS, SELIG LUC, FLAENDER MELANIE, DUIN-PELLETIER EVE
Year of Publication 30.10.2020
Get full text
Year of Publication 30.10.2020
Patent
Loading…
Loading…
Loading…